Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Abramowitz

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Oncology (Williston Park, N.Y.)|August 9, 2012
Hypofractionated radiotherapy for prostate cancer: has the time come?Matthew C Abramowitz, Alan Pollack
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Weighing the Addition of Androgen Suppression Therapy to Radiotherapy Dose Escalation for Intermediate-Risk Prostate CancerAlan Pollack, Matthew C Abramowitz
Seminars in Radiation Oncology|December 18, 2007
Postprostatectomy radiation therapy for prostate cancerMatthew C Abramowitz, Alan Pollack
Translational Andrology and Urology|July 28, 2018
Contemporary role of postoperative radiotherapy for prostate cancerAlan Dal Pra, Matthew C Abramowitz, Radka Stoyanova, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 22, 2020
The role of radiomics in prostate cancer radiotherapyRodrigo Delgadillo, John C Ford, Matthew C Abramowitz, et al.
Head & Neck|May 13, 2015
Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysisDayssy Alexandra Diaz, Isildinha M Reis, Donald T Weed, et al.
Journal of Applied Clinical Medical Physics|May 12, 2016
Quantification of the margin required for treating intraprostatic lesionsMatthew T Studenski, Yanisley Valenciaga, Matthew C Abramowitz, et al.
American Journal of Clinical Oncology|February 6, 2009
Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiationMatthew C Abramowitz, Tianyu Li, Monica Morrow, et al.
Cancer|October 31, 2007
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancerMatthew C Abramowitz, Tiaynu Li, Mark K Buyyounouski, et al.
Frontiers in Oncology|July 30, 2014
Concurrent radiotherapy with Carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinomaKunal Saigal, Edgardo S Santos, Khaled Tolba, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Oncology (Williston Park, N.Y.)|August 9, 2012
Hypofractionated radiotherapy for prostate cancer: has the time come?Matthew C Abramowitz, Alan Pollack
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Weighing the Addition of Androgen Suppression Therapy to Radiotherapy Dose Escalation for Intermediate-Risk Prostate CancerAlan Pollack, Matthew C Abramowitz
Seminars in Radiation Oncology|December 18, 2007
Postprostatectomy radiation therapy for prostate cancerMatthew C Abramowitz, Alan Pollack
Translational Andrology and Urology|July 28, 2018
Contemporary role of postoperative radiotherapy for prostate cancerAlan Dal Pra, Matthew C Abramowitz, Radka Stoyanova, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 22, 2020
The role of radiomics in prostate cancer radiotherapyRodrigo Delgadillo, John C Ford, Matthew C Abramowitz, et al.
Head & Neck|May 13, 2015
Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysisDayssy Alexandra Diaz, Isildinha M Reis, Donald T Weed, et al.
Journal of Applied Clinical Medical Physics|May 12, 2016
Quantification of the margin required for treating intraprostatic lesionsMatthew T Studenski, Yanisley Valenciaga, Matthew C Abramowitz, et al.
American Journal of Clinical Oncology|February 6, 2009
Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiationMatthew C Abramowitz, Tianyu Li, Monica Morrow, et al.
Cancer|October 31, 2007
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancerMatthew C Abramowitz, Tiaynu Li, Mark K Buyyounouski, et al.
Frontiers in Oncology|July 30, 2014
Concurrent radiotherapy with Carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinomaKunal Saigal, Edgardo S Santos, Khaled Tolba, et al.
Pageof 6